New stimulation device hopes to restore limb function after brain and spinal injuries

NCT ID NCT07396922

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called SSMD, which uses non-invasive stimulation to help people with movement problems after stroke, traumatic brain injury, spinal cord injury, or peripheral nerve damage. 120 adults aged 18-80 with moderate to severe arm impairment will receive either the SSMD device or standard electrical stimulation, plus usual therapy, for 18 sessions over 3 weeks. The main goal is to see if the SSMD device improves arm motor function more than standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SSMD device (non-invasive stimulation device)
What this could lead to
If it works, this could offer a new non-invasive option to improve arm and hand function after neurological injury.
What could go wrong
This is a small, early-stage trial with only 120 participants over 3 weeks. The device may not provide meaningful improvement over standard therapy, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Polsko-Amerykańskie Kliniki Serca SA, Uzdrowisko Ustroń

    Ustroń, 43-450, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.